Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

Denver TMAU Test Lab survey click here
click to Read more/less

USA survey for anyone who wants to improve Denver TMAU test

begun : Dec22
end : no ending for now

A trainee genetic counselor is working at the Denver TMAU test lab. Probably as part of her training. As a project she wishes feedback on any aspect of the Denver TMAU test and process. You can fill in the survey and/or email her (email address is in survey). It's meant for USA people, but perhaps others can give their view too (as we have so few opportunities).

quote from her rareconnect post

"Hello all! I wanted to make you aware of a research study being conducted to better understand the experience and needs of individuals with trimethylaminuria with a goal of being able to create improved patient and healthcare provider education materials. Any participation is completely voluntary and all responses remain confidential. Feel free to use the contact information within the link with any questions or share the survey with others with TMAU."

see this post for more details

Monday, October 26, 2009

Expert overseeing MEBO Research Studies

we are most grateful to Dr. Irene Gabashvili, PhD, for overseeing MEBO Research's exploratory trials. She brings with her years of experience in biomedical industry and academia. Dr. Irene is the founder of Aurametrix, which she continues to develop as she works very closely with the MEBO community to address our needs.  She heads the MEBO directorship as we explore new groundbreaking research possibilities in an effort to develop accurate diagnosis, treatment and a cure to the various types of body and breath odor conditions.

Throughout her career, Dr. Gabashvili has been interested in the molecular, cellular, and physiological mechanisms of health and disease. She developed models and data analysis approaches and experimentally studied physics of microbial infection, chemistry of light and radiation effects on living matter, plant enzymes, structural basis of antibiotic resistance, human pathologies dependent on variation in mitochondrial genes, development of sensory apparatus and aging, and inheritance and environmental factors contributing to the development of diseases.

Dr. Gabashvili was overseeing exploratory trials and data mining studies in the past, working with medical doctors and supervising MD students. For example, she studied analysis of blood biomarkers to determine patterns of longevity at the Center of Genetic Ecology. She worked in microbiology, molecular biology, biochemistry and biophysics labs and was utilizing state-of-the-art techniques and instrumentation to characterize macro- and micro-molecules causing or protecting from disease. She continues to collaborate with experimental labs, in particular employing novel chromatographic and mass spectrometry approaches to identify disease biomarkers.

Dr. Gabashvili has developed software tools and IT infrastructure to support research and clinical processes. She worked with and for Hewlett Packard, Merck, Pfizer, Johnson & Johnson, Novartis, etc. Her academic partnerships include renowned scientists and clinicians from Stanford and Harvard Universities.

Dr. Gabashvili demonstrated a concerted interest in applying her wealth of knowledge to MEBO's research aims for the betterment of our community. She is especially interested in clinical nutrition and the complex relationship between the human immune system with trillions of microbes populating human beings. You can contact her directly by e-mailing to Irene at

Irene Gabashvili, PhD
Scientific Director, MEBO Research
Founder of Aurametrix &

See Slideshow presentation "Microbes and Us"
Alphabetical List of Pathogenic Bacteria


María de la Torre
Founder and Executive Director

A Public Charity (MEBO Brasil)
The MEBO Blog (English)
El Blog de MEBO (español) 
NORD Member Organization
EURORDIS Member Organisation 

SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online
at no extra cost to you.
MEBO gets small commission from Amazon.

Please use your credit card to make your donation to MEBO.

Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner

A EURORDIS and NORD Member Organization


Post a Comment